The global oncology landscape is undergoing a significant transformation, with the 5-Fluorouracil Market remaining a cornerstone of chemotherapy regimens worldwide. 5-Fluorouracil (5-FU), an antimetabolite that inhibits DNA synthesis, has been a clinical gold standard for decades in the treatment of various malignancies, including colorectal, breast, and gastrointestinal cancers. As we look...